Two-wavelength near-infrared fluorescence for the quantitation of drug antiplatelet effects in large animal model systems

J Vasc Surg. 2012 Jul;56(1):171-80. doi: 10.1016/j.jvs.2011.11.058. Epub 2012 Apr 14.

Abstract

Objective: Intraoperative imaging of intravascular thrombi is limited by the inability of visible light to penetrate thick-walled vessels. Near-infrared (NIR) light has relatively high tissue penetration and low autofluorescence and scatter, offering significant advantages. We hypothesized that the development of 700-nm NIR fluorophores for platelet labeling, in conjunction with existing 800-nm NIR fluorophores, would permit simultaneous and separable quantitation of intravascular thrombi and measurement of the antiplatelet effect of drugs.

Methods: We synthesized a series of lipophilic, cationic, polymethine indocyanine dyes (MHI-86, 94, 106, and 114) that emit at approximately 700 nm. Platelet uptake was optimized in vitro and the bioactivity and blood half-life of labeled platelets was characterized in vitro and in vivo. FeCl(3)-induced injury of the femoral arteries and intravascular thrombus formation was performed in 35-kg Yorkshire pigs. A combination of 700-nm and 800-nm NIR fluorophore-labeled platelets was used in conjunction with the fluorescence-assisted resection and exploration imaging system to image and quantify the antiplatelet effect of cilostazol and acetylsalicylic acid.

Results: MHI-114 was incorporated at nearly 4.1 × 10(6) molecules per platelet without affecting platelet function. When infused into pigs, the signal-to-background ratio of MHI-114-labeled platelets exhibited a blood half-life of 16.4 ± 2.2 (mean ± SEM; n = 3) minute and generated a signal-to-background ratio of 2.5 ± 0.5 (mean ± SEM; n = 3) at the site of thrombi. Using dual-NIR-labeled platelet populations, cilostazol and acetylsalicylic acid were found to cause a reduction in platelet incorporation into thrombi of 51 ± 2% and 10 ± 1% (mean ± SEM; n = 3), respectively, relative to vehicle-only treated control thrombi.

Conclusions: New platelet-avid 700-nm NIR fluorophores permit simultaneous two-wavelength NIR fluorescence imaging and quantitation of intravascular thrombi in intact vessels approaching the size of humans and can be used to study the antiplatelet effect of drugs.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Analysis of Variance
  • Animals
  • Aspirin / pharmacology*
  • Blood Platelets / metabolism*
  • Cilostazol
  • Disease Models, Animal
  • Female
  • Femoral Artery*
  • Fluorescent Dyes / chemical synthesis*
  • Half-Life
  • Humans
  • Molecular Structure
  • Platelet Aggregation Inhibitors / pharmacology*
  • Spectroscopy, Near-Infrared / methods*
  • Swine
  • Tetrazoles / pharmacology*
  • Thrombosis / diagnosis*
  • Thrombosis / surgery

Substances

  • Fluorescent Dyes
  • Platelet Aggregation Inhibitors
  • Tetrazoles
  • Cilostazol
  • Aspirin